Breaking News
Get 50% Off 0
😎 Summer Sale Exclusive - Up to 50% off AI-powered stock picks by InvestingPro CLAIM SALE
Close

Roche Holding Ltd ADR (RHHBY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
39.36 +0.09    +0.23%
16:00:58 - Closed. Currency in USD ( Disclaimer )
After Hours
39.38
-0.00
-0.00%
16:02:42 - Delayed Data
Type:  Equity
Market:  United States
  • Volume: 1,824,554
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 39.27 - 39.50
Roche Holding ADR 39.36 +0.09 +0.23%

Roche Holding Ltd ADR Company Profile

 
Get an in-depth profile of Roche Holding Ltd ADR, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

103605

Equity Type

ADR

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Contact Information

Address Grenzacherstrasse 124
Basel, 4058
Switzerland
Phone 41 61 688 11 11
Fax 41 61 691 00 14

Top Executives

Name Age Since Title
Bernard J. Poussot 71 2015 Non-Executive Independent Director
Andre S. Hoffmann 65 1996 Independent Vice Chairman
Richard P. Lifton 70 2015 Non-Executive Independent Director
Jorg Duschmale 39 2020 Non-Executive Independent Director
Patrick Frost 55 2020 Independent Non Executive Director
Anita Hauser 54 2017 Non-Executive Independent Director
Jemilah Mahmood - 2022 Independent Non-Executive Director
Ulf Mark Schneider 58 2023 Director
Akiko Iwasaki - 2023 Director
Severin Schwan 56 2006 Executive Chairman
Claudia Ricarda Rita Suessmuth Dyckerhoff 57 2016 Non-Executive Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RHHBY Comments

Write your thoughts about Roche Holding Ltd ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Julian Qt
Julian Qt Jun 08, 2020 2:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it will go up: the chart formed an "bulllish doji star"
Patryk Słowik
Patryk Słowik Mar 24, 2020 7:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This Is one and only real competitor in covid test from POLAND http://scopefluidics.com/scope-fluidics-is-developing-an-ultra-fast-covid-19-panel-for-its-pcrone-rapid-molecular-diagnostic-system/
john alvitre
john alvitre Mar 13, 2020 3:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Roche just announced as the test pushed through for Covid 19 Tessting. Up Up Up!
roy reyes
roy reyes Jan 26, 2020 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Jan 26, 2020 Sun $41.20 its GENE is dazzling as always focusing on breakthrough sciences
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email